235 related articles for article (PubMed ID: 24430361)
1. Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India.
Chattopadhyay S; Siddiqui S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
Tumour Biol; 2014 May; 35(5):4517-27. PubMed ID: 24430361
[TBL] [Abstract][Full Text] [Related]
2. Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.
Kaur R; Kaur T; Kaur A
J Assist Reprod Genet; 2018 Jun; 35(6):1123-1129. PubMed ID: 29564739
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone-related gene variants and colorectal cancer risk in women.
Lin JH; Manson JE; Kraft P; Cochrane BB; Gunter MJ; Chlebowski RT; Zhang SM
BMC Med Genet; 2011 May; 12():78. PubMed ID: 21627810
[TBL] [Abstract][Full Text] [Related]
4. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
Ghali RM; Al-Mutawa MA; Al-Ansari AK; Zaied S; Bhiri H; Mahjoub T; Almawi WY
Gene; 2018 Apr; 651():194-199. PubMed ID: 29414691
[TBL] [Abstract][Full Text] [Related]
5. New evidence for involvement of ESR1 gene in susceptibility to Chinese migraine.
An X; Fang J; Lin Q; Lu C; Ma Q; Qu H
J Neurol; 2017 Jan; 264(1):81-87. PubMed ID: 27778160
[TBL] [Abstract][Full Text] [Related]
6. Risk for estrogen-dependent diseases in relation to phthalate exposure and polymorphisms of CYP17A1 and estrogen receptor genes.
Huang PC; Li WF; Liao PC; Sun CW; Tsai EM; Wang SL
Environ Sci Pollut Res Int; 2014 Dec; 21(24):13964-73. PubMed ID: 25030786
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis.
Lamp M; Peters M; Reinmaa E; Haller-Kikkatalo K; Kaart T; Kadastik U; Karro H; Metspalu A; Salumets A
Gynecol Endocrinol; 2011 Jun; 27(6):425-33. PubMed ID: 20586553
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic variants in Estrogen receptor (ESR)1 and ESR2 with susceptibility to recurrent pregnancy loss in Tunisian women: A case control study.
Bahia W; Soltani I; Haddad A; Soua A; Radhouani A; Mahdhi A; Ferchichi S
Gene; 2020 Apr; 736():144406. PubMed ID: 32007580
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer Cases.
Tüzüner MB; Öztürk T; Eronat AP; Seyhan F; Kısakesen Hİ; Calay Z; İlvan Ş; Turna H; Yılmaz-Aydoğan H; Bermek H; Öztürk O
Biochem Genet; 2016 Dec; 54(6):784-802. PubMed ID: 27365044
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Receptor 1 Gene (ESR1) rs2234693 Polymorphism and Breast Cancer Risk in Saudi Women.
Al-Amri RJ; Alotibi MKH; Al-Raddadi RI; Shebli WTY; Fallatah EIY; Alhujaily AS; Mohamed HS
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3235-3240. PubMed ID: 33247680
[TBL] [Abstract][Full Text] [Related]
14. Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.
Zheng Y; Huo D; Zhang J; Yoshimatsu TF; Niu Q; Olopade OI
PLoS One; 2012; 7(7):e40494. PubMed ID: 22792352
[TBL] [Abstract][Full Text] [Related]
15. Variants in estrogen-related genes and risk of Parkinson's disease.
Chung SJ; Armasu SM; Biernacka JM; Lesnick TG; Rider DN; Cunningham JM; Maraganore DM
Mov Disord; 2011 Jun; 26(7):1234-42. PubMed ID: 21469201
[TBL] [Abstract][Full Text] [Related]
16. Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North India.
Ghosh J; Joshi G; Pradhan S; Mittal B
PLoS One; 2012; 7(4):e34828. PubMed ID: 22511967
[TBL] [Abstract][Full Text] [Related]
17. Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
Tsezou A; Tzetis M; Gennatas C; Giannatou E; Pampanos A; Malamis G; Kanavakis E; Kitsiou S
Breast; 2008 Apr; 17(2):159-66. PubMed ID: 17904846
[TBL] [Abstract][Full Text] [Related]
18. Contribution of polymorphisms in ESR1, ESR2, FSHR, CYP19A1, SHBG, and NRIP1 genes to migraine susceptibility in Turkish population.
CoŞkun S; Yůcel Y; Çim A; Cengiz B; Oztuzcu S; Varol S; Özdemir HH; Uzar E
J Genet; 2016 Mar; 95(1):131-40. PubMed ID: 27019440
[TBL] [Abstract][Full Text] [Related]
19. Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study.
Al-Eitan LN; Rababa'h DM; Alghamdi MA; Khasawneh RH
BMC Cancer; 2019 Dec; 19(1):1257. PubMed ID: 31888550
[TBL] [Abstract][Full Text] [Related]
20. Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus.
Wang J; Nuite M; McAlindon TE
Lupus; 2010 May; 19(6):734-40. PubMed ID: 20305046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
